US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

683.34

-30.9683-4.34%

Number of Gainers:33

Number of Losers:113

Number of Flat:7

PE:- -

High:711.28

Open:710.98

Low:683.27

Close:714.31

Volume:255.46M

Turnover:8.25B

Market Cap:475.30B

Float Cap:360.72B

Loading ...

UiPath Appoints Kaiser Permanente Executive Yazdi Bagli to Board

UiPath Announces Executive Leadership Changes, Appoints New Board Member

THOMSON REUTERS

UiPath Q2 Revenue USD 410 Million Vs. IBES Estimate USD 397.9 Million

UiPath Q2 Adjusted Gross Margin 82%

THOMSON REUTERS

UiPath - Appoints Hitesh Ramani as Chief Financial Officer

THOMSON REUTERS

Torrid Q2 FY26 Net Income Rises to $5.2 Million; Net Sales Fall 11.8% to $231.7 Million

Flywire CEO Michael Massaro Disposes of 112,500 Shares Worth $2.07 Million

Doximity Director Kira Scherer Wampler Disposes of 2,000 Common Shares Worth $52,660

Torrid Holdings Q2 Net Sales USD 231.727 Million Vs. IBES Estimate USD 238.1 Million

Privia Health Files Form 3 for Director Ernest Opella Finley

Torrid Reports Second Quarter 2026 Results and Updates Fiscal 2026 Guidance

THOMSON REUTERS

Torrid Holdings Q2 EBIT USD 14.539 Million

THOMSON REUTERS

Torrid Holdings Inc: During Quarter, We Received $11.4 Mln in Ieepa Tariff Benefits

THOMSON REUTERS

Torrid Holdings Outlook FY Net Sales $940 Million - $960 Million.

THOMSON REUTERS

Torrid Holdings Q2 EPS USD 0.05

THOMSON REUTERS

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Immuneering to Participate in Upcoming Investor Conferences

Rein Therapeutics to Present at Upcoming September Investor Conferences

Coinbase files to bring stock perpetuals to the US

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/BK4539/news?page=35"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":683.3368,"timestamp":1789498162044,"preClose":714.30505,"halted":0,"volume":255459247,"delay":0,"changeRate":-0.043354,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-30.968262,"latestTime":"09-15 14:49:22 EDT","open":710.9754,"high":711.27765,"low":683.2717,"amount":8254261661.97726,"amplitude":0.039207,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789502400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.340053,"peRate":116.830865,"turnoverRate":0.019972,"increases":33,"decrements":113,"flats":4,"marketCap":475297840658.25,"floatMarketCap":360718552850.875},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":711.27765,"amplitude":0.039207,"preClose":714.30505,"low":683.2717,"pbRate":"5.340053","latestPrice":683.3368,"volume":255459326,"delay":0,"open":710.9754,"prevYearClose":881.5255,"prevWeekClose":693.0266,"prevMonthClose":701.0681,"prevQuarterClose":742.922,"fiveDayClose":705.7056,"twentyDayClose":666.772,"sixtyDayClose":727.8837,"secType":"PLATE","market":"US","turnoverRate":0.019972,"peRate":116.830865,"marketCap":475297840658.25,"floatMarketCap":360718552850.875,"timestamp":1789498162074,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":33,"down":113,"flat":7},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:35,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664801360","title":"UiPath Appoints Kaiser Permanente Executive Yazdi Bagli to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2664801360","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664801360?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:12","pubTimestamp":1788466364,"startTime":"0","endTime":"0","summary":"UiPath appoints Kaiser Permanente executive Yazdi Bagli to boardUiPath promoted Hitesh Ramani to chief financial officer, shifting him from chief accounting officer, then deputy CFO.Ramani brings more than 25 years of finance leadership, including two decades at Deloitte as a partner serving SEC registrants.Brad Brubaker was named chief legal and administrative officer, expanding his remit beyond chief legal officer and general counsel.Brubaker joined in 2019 from SAP, where he spent over 25 years, most recently as general counsel for global field legal.Yazdi Bagli joined the board, currently EVP of IT and enterprise business services at Kaiser Permanente, previously leading roles at Walmart, P&G.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL4Q9F25:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4097","PATH","BK4588","BK4547","BK4561","BK4505","BK4551","PATX","BK4543","BK4539","LU1861558580.USD","BK4604","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664480131","title":"UiPath Announces Executive Leadership Changes, Appoints New Board Member","url":"https://stock-news.laohu8.com/highlight/detail?id=2664480131","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664480131?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:12","pubTimestamp":1788466320,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUAZM2KJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PATH","LU1861558580.USD","BK4547","BK4505","BK4561","BK4588","PATX","LU1861559042.SGD","BK4604","BK4097","BK4539","BK4543","BK4551","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664013548","title":"UiPath Q2 Revenue USD 410 Million Vs. IBES Estimate USD 397.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2664013548","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664013548?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:11","pubTimestamp":1788466261,"startTime":"0","endTime":"0","summary":"BRIEF-UiPath Q2 Revenue USD 410 Million Vs. IBES Estimate USD 397.9 MillionSep 03 (Reuters) - UiPath Q2 adjusted operating income USD 89 million.Q2 adjusted gross margin 82%Q2 gross margin 80%Q2 ARR USD 1,938 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nPLXDLFKCX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861559042.SGD","BK4588","LU1861558580.USD","BK4547","BK4585","PATH","BK4539","PATX","BK4604","BK4561","BK4543","BK4097","BK4551","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664980187","title":"UiPath Q2 Adjusted Gross Margin 82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664980187","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664980187?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:10","pubTimestamp":1788466201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nPLXDLFKCX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PATX","BK4561","LU1861558580.USD","BK4539","BK4604","BK4097","BK4585","LU1861559042.SGD","BK4588","BK4543","BK4551","BK4547","PATH","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664870801","title":"UiPath - Appoints Hitesh Ramani as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2664870801","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664870801?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:10","pubTimestamp":1788466201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nPLXDLFKCX:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","LU1861558580.USD","PATX","LU1861559042.SGD","BK4097","BK4588","BK4505","BK4561","BK4551","BK4604","BK4547","BK4539","BK4543","PATH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664019809","title":"Torrid Q2 FY26 Net Income Rises to $5.2 Million; Net Sales Fall 11.8% to $231.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2664019809","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664019809?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:07","pubTimestamp":1788466033,"startTime":"0","endTime":"0","summary":"Torrid Q2 FY26 net income rises to $5.2 million; net sales fall 11.8% to $231.7 millionTorrid posted Q2 net income of $5.2 million, or $0.05 a share, up from $1.6 million a year earlier.Net sales fell","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL3MkD5W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","CURV","BK4094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664090178","title":"Flywire CEO Michael Massaro Disposes of 112,500 Shares Worth $2.07 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2664090178","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664090178?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:07","pubTimestamp":1788466031,"startTime":"0","endTime":"0","summary":"Flywire CEO Michael Massaro disposes of 112,500 shares worth $2.07 millionFlywire CEO Michael Massaro sold 112,500 voting common shares on Sep. 1 at a weighted average USD 18.39.Separately, 39,993 sha","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDLbQf1CC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Flywire CEO Michael Massaro Disposes of 112,500 Shares Worth $2.07 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4106","BK4535","LU1815336091.USD","BK4539","LU0757428866.USD","BK4227","FLYW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664809724","title":"Doximity Director Kira Scherer Wampler Disposes of 2,000 Common Shares Worth $52,660","url":"https://stock-news.laohu8.com/highlight/detail?id=2664809724","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664809724?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:06","pubTimestamp":1788465995,"startTime":"0","endTime":"0","summary":"Doximity director Kira Scherer Wampler disposes of 2,000 common shares worth $52,660Doximity director Kira Scherer Wampler sold 2,000 Class A common shares on Sept. 1 at USD 26.33.The transaction redu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL7d4gGQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Doximity Director Kira Scherer Wampler Disposes of 2,000 Common Shares Worth $52,660","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","DOCS","BK4613","BK4539","BK4551","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664580970","title":"Torrid Holdings Q2 Net Sales USD 231.727 Million Vs. IBES Estimate USD 238.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2664580970","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664580970?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:06","pubTimestamp":1788465961,"startTime":"0","endTime":"0","summary":"BRIEF-Torrid Holdings Q2 Net Sales USD 231.727 Million Vs. IBES Estimate USD 238.1 MillionSep 03  - Torrid Holdings Q2 adjusted EBITDA USD 23.25 million vs. IBES estimate USD 17.2 million.Q2 net income USD 5.177 millionQ2 pretax profit USD 6.55 millionQ2 gross profit USD 89.747 millionQ2 EBIT USD 14.539 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nPLXHLTVLV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4094","CURV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664809737","title":"Privia Health Files Form 3 for Director Ernest Opella Finley","url":"https://stock-news.laohu8.com/highlight/detail?id=2664809737","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664809737?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:05","pubTimestamp":1788465924,"startTime":"0","endTime":"0","summary":"Privia Health files Form 3 for director Ernest Opella FinleyPrivia Health filed a Form 3 naming Ernest Opella Finley as a director, effective Sept. 1, 2026.Disclaimer:This news brief was created by Pu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL1xBb1n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4539","BK4196","PRVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664880928","title":"Torrid Reports Second Quarter 2026 Results and Updates Fiscal 2026 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2664880928","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664880928?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:05","pubTimestamp":1788465902,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUA58PWR8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CURV","BK4539","BK4094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664809228","title":"Torrid Holdings Q2 EBIT USD 14.539 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2664809228","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664809228?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:05","pubTimestamp":1788465901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nPLXHLTVLV:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CURV","BK4539","BK4094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664801317","title":"Torrid Holdings Inc: During Quarter, We Received $11.4 Mln in Ieepa Tariff Benefits","url":"https://stock-news.laohu8.com/highlight/detail?id=2664801317","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664801317?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:05","pubTimestamp":1788465901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nPLXHLTVLV:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4094","CURV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664535801","title":"Torrid Holdings Outlook FY Net Sales $940 Million - $960 Million.","url":"https://stock-news.laohu8.com/highlight/detail?id=2664535801","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664535801?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:05","pubTimestamp":1788465901,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nPLXHLTVLV:10","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","CURV","BK4094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664013748","title":"Torrid Holdings Q2 EPS USD 0.05","url":"https://stock-news.laohu8.com/highlight/detail?id=2664013748","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664013748?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:05","pubTimestamp":1788465901,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nPLXHLTVLV:8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4094","BK4539","CURV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664801125","title":"Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664801125","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664801125?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:05","pubTimestamp":1788465900,"startTime":"0","endTime":"0","summary":"BOSTON, Sept.  03, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX) (Tango Therapeutics or the Company) today announced that, effective September 1, 2026, the Compensation Committee of","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3356254/0/en/tango-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LENZ","BK4539","LCLG","BK4139","TNGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664159801","title":"Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664159801","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664159801?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:05","pubTimestamp":1788465900,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Sept.  03, 2026 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company focused on advancing next-generation medicines in immunology a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3356262/0/en/spero-therapeutics-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4007","BK4539","LCLG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664011558","title":"Immuneering to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664011558","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664011558?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:05","pubTimestamp":1788465900,"startTime":"0","endTime":"0","summary":"NEW YORK, Sept.  03, 2026 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, today ann","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3356257/0/en/immuneering-to-participate-in-upcoming-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMRX","BK4539","BK4563","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664801129","title":"Rein Therapeutics to Present at Upcoming September Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664801129","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664801129?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:01","pubTimestamp":1788465660,"startTime":"0","endTime":"0","summary":"AUSTIN, Texas, Sept.  03, 2026  -- Rein Therapeutics  , a biopharmaceutical company advancing a novel pipeline of first-in-class medicines in orphan pulmonary and fibrosis indications, today announced that Brian Windsor, President and Chief Executive Officer of Rein Therapeutics, will present at the following investor conferences in September. 2026 Cantor Global Healthcare Conference Date & Time: Friday, September 11, 2026, at 8:00 a.m. ETLocation: New York, NY H.C. Wainwright 28th Annual Global Investment Conference Date: Monday, September 14, 2026 at 11:00 a.m. ETLocation: New York, NY A live webcast of the presentations may be accessed via the Investors section of the Rein website at ir.reintx.com. An archived replay of the events will be available on the website for approximately 90 days following the conference. About Rein Therapeutics Rein Therapeutics is a clinical-stage biopharmaceutical company advancing a novel pipeline of first-in-class therapies to address significant unmet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3356233/28652/en/rein-therapeutics-to-present-at-upcoming-september-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNTX","BK4539","BK4007","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664809422","title":"Coinbase files to bring stock perpetuals to the US","url":"https://stock-news.laohu8.com/highlight/detail?id=2664809422","media":"cryptonews","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664809422?lang=en_us&edition=fundamental","pubTime":"2026-09-04 03:58","pubTimestamp":1788465497,"startTime":"0","endTime":"0","summary":"Coinbase has filed two SEC notice registrations dated Sept. 1 as it works to bring single-stock perpetual contracts to the United States through its regulated derivatives exchange and brokerage.Coinbase Derivatives filed Form 1-N to register as a security futures exchange.Coinbase Financial Markets submitted Form BD-N as a limited-purpose security futures broker-dealer.The filings do not provide a launch date, a list of supported stocks, or proposed leverage limits.Single-stock futures fall under the joint oversight of the SEC and CFTC.Coinbase said in a Sep. 3 post on X that it is working to offer single-stock perpetual contracts in the United States after submitting SEC notice registrations for two of its regulated derivatives businesses.“We’re working to bring single stock perps to the US,” the company said.The two filings therefore cover distinct functions: Coinbase Derivatives would provide the market where contracts are listed, while Coinbase Financial Markets wou","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"crypto_news_highlight","url":"https://crypto.news/coinbase-files-to-bring-stock-perpetuals-to-the-us/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://crypto.news/coinbase-files-to-bring-stock-perpetuals-to-the-us/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"crypto_news_highlight","symbols":["FDIG","LU1861559042.SGD","COIN","09311","COIG","07711","COIA","COIX","COIO","09711","BK4516","BK4535","CONL","CONY","LU1861220207.SGD","BK4554","LU1861217088.USD","07311","CONX","BK4551","LU1861558580.USD","IBLC","COIW","BK4596","ICOI","BK4595","BK4585","LU2360107671.USD","BK4539","FINX","BLCK","COII","FIAT","BK4588","BK4112","COYY","BK4600","CONI"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":45,"pageCount":35,"totalSize":887,"code":"91000000","status":"200"}]}}